Aronsson M, Bergman S, Lindqvist E, Andersson M L E
Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Faculty of Medicine, Lund, Sweden.
Spenshult Research and Development Center, Bäckagårdsvägen 47, Halmstad, 302 74, Sweden.
Arthritis Res Ther. 2024 Dec 23;26(1):228. doi: 10.1186/s13075-024-03463-x.
High body mass index (BMI) has been shown to have an association with chronic widespread pain (CWP), both in Rheumatoid arthritis (RA) and in other pain conditions such as fibromyalgia. Research on the adipose tissue and it's adipokines, for example the well described leptin, is emerging. The objective of this study was to determine if there is an association between leptin levels in blood and CWP in patients with RA.
In this cross-sectional study 334 patients with RA filled in a questionnaire including a pain mannequin and questions on weight, length and waist circumference. Data from the pain mannequin was used to calculate CWP. The subjects also submitted blood samples to a biobank that were used for this study to determine leptin levels using an ELISA-method.
Patients fulfilling the 2019 criteria for CWP in this study had significantly higher leptin levels, waist circumferences and BMI. There was a significant association between leptin levels and CWP, odds ratio (OR) 1.014 (95% confidence interval (CI) 1.007-1.020), p < 0.001. The association remained after adjusting for BMI, gender and age OR 1.008 (95% CI 1.000-1.017), p 0.046. When leptin was divided into quartile groups a trend could be observed where higher leptin values gave higher OR for CWP.
This study showed an increased occurrence of CWP in RA-patients with high leptin levels. The association between leptin and CWP remained after adjusting for gender, age and BMI or waist circumference. This suggests that not just production of leptin in the adipose tissue, but also other factors such as leptin resistance may play a role. The association between leptin and CWP was strongest in the patients with the highest leptin levels.
This study is a cross-sectional study without intervention and the cohort used was initiated prior to the implementation of mandatory registration requirements, therefore it is not registered.
高体重指数(BMI)已被证明与类风湿关节炎(RA)以及纤维肌痛等其他疼痛病症中的慢性广泛性疼痛(CWP)有关。关于脂肪组织及其脂肪因子(例如已被充分描述的瘦素)的研究正在兴起。本研究的目的是确定RA患者血液中的瘦素水平与CWP之间是否存在关联。
在这项横断面研究中,334名RA患者填写了一份问卷,其中包括疼痛人体模型以及关于体重、身高和腰围的问题。疼痛人体模型的数据用于计算CWP。受试者还向生物样本库提交了血液样本,本研究使用酶联免疫吸附测定(ELISA)方法来测定瘦素水平。
本研究中符合2019年CWP标准的患者瘦素水平、腰围和BMI显著更高。瘦素水平与CWP之间存在显著关联,比值比(OR)为1.014(95%置信区间[CI] 1.007 - 1.020),p < 0.001。在调整BMI、性别和年龄后,该关联仍然存在,OR为1.008(95% CI 1.000 - 1.017),p = 0.046。当将瘦素分为四分位数组时,可以观察到一种趋势,即瘦素值越高,CWP的OR越高。
本研究表明,瘦素水平高的RA患者中CWP的发生率增加。在调整性别、年龄和BMI或腰围后,瘦素与CWP之间的关联仍然存在。这表明不仅脂肪组织中瘦素的产生,而且诸如瘦素抵抗等其他因素可能也起作用。瘦素与CWP之间的关联在瘦素水平最高的患者中最为明显。
本研究是一项无干预的横断面研究,所使用的队列是在强制注册要求实施之前启动的,因此未进行注册。